2017 ACR/ARHP Annual Meeting

November 3-8, 2017. San Diego, CA.

View by Number View by Title View Sessions

View by Date

Abstract Number: 1859

Meeting the Needs of Rheumatology Health Professional Learners: the Success of the American College of Rheumatology (ACR) and Association of Rheumatology Health Professionals (ARHP) Online Educational Products
Abstract Number: 1860

A Trial Testing Strategies to Enhance Patient Understanding of Drug Information: Experience Recruiting Subjects through an Online Patient Community
Abstract Number: 1861

Evaluation of a Longstanding Telephone Peer Counseling Service on People with Systemic Lupus Erythematosus and Their Loved Ones
Abstract Number: 1862

Association between Hydroxychloroquine Nonadherence and Adverse Outcomes Among Patients with Systemic Lupus Erythematosus
Abstract Number: 1863

Inflammatory Dietary Pattern and Risk of Developing Rheumatoid Arthritis in Women
Abstract Number: 1864

Longitudinal Changes in Serum Uric Acid Levels and Associated Risk of Cardiometabolic Events and Renal Insufficiency in Gout Patients
Abstract Number: 1865

Novel Approach to Arthritis Surveillance Suggests a Much Higher Prevalence of Arthritis Among US Adults Than Previous Estimate
Abstract Number: 1866

Use of Aromatase Inhibitors and Risk of Arthritis and Musculoskeletal Problems Among Taiwanese Women with Breast Cancer: A Nationwide Claims Analysis
Abstract Number: 1867

Can Vs. Do: Using Walking Speed and Moderate-to-Vigorous Physical Activity to Predict Incident Low Health-Related Quality of Life and Disability
Abstract Number: 1868

Association between Brain-Derived Neurotrophic Factor Gene Polymorphisms and Fibromyalgia in a Korean Population: A Multi-Center Study
Abstract Number: 1869

Effects of Add-on Transcranial Direct Current Stimulation on Pain in Korean Patients with Fibromyalgia
Abstract Number: 1870

Validation of an Electronic Version of the Michigan Body Map
Abstract Number: 1871

Identifying Pain Sites Highly Associated with the Fibromyalgia (FM) Phenotype
Abstract Number: 1872

The Effect of EEG-Amygdala-Related-Neurofeedback on REM Latency in Patients with Fibromyalgia
Abstract Number: 1873

Evaluating Pain Related Disability in Fibromyalgia: A Comparison of the Fibromyalgia Impact Questionnaire and the Polysymptomatic Distress Scale

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].